| KRT18 |
KRT18: Uncharacterized protein KRT18 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
3.132 |
Evidence |
O
|
| CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
3.125 |
Evidence |
|
| APEX1 |
APEX1, APE, APEX, APX, HAP1, REF1: DNA-(apurinic or apyrimidinic site) lyase |
FEN1 |
FEN1, RAD2: Flap endonuclease 1 |
3.115 |
Evidence |
O
|
| FEN1 |
FEN1, RAD2: Flap endonuclease 1 |
WRN |
WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase |
3.115 |
Evidence |
O
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
3.115 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
3.107 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
KRT8 |
KRT8, CYK8: Keratin, type II cytoskeletal 8 |
3.077 |
Evidence |
|
| CRYGC |
CRYGC, CRYG3: Gamma-crystallin C |
CRYBB2 |
CRYBB2, CRYB2, CRYB2A: Beta-crystallin B2 |
3.077 |
Evidence |
O
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
3.055 |
Evidence |
O
|
| SNTG1 |
SNTG1: Gamma-1-syntrophin |
DTNA |
DTNA, DRP3: Dystrobrevin alpha |
3.055 |
Evidence |
|
| NRAS |
HRAS, HRAS1: GTPase HRas precursor |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
3.045 |
Evidence |
O
|
| K-ALPHA-1 |
TUBA1A, TUBA3: Tubulin alpha-1A chain |
TUBB2A |
TUBB2A, TUBB2: Tubulin beta-2A chain |
3.037 |
Evidence |
|
| POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
3.02 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
3.02 |
Evidence |
O
|
| RRAGA |
RRAGA: Ras-related GTP-binding protein A |
RRAGC |
RRAGC: Ras-related GTP-binding protein C |
3.012 |
Evidence |
O
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
3.007 |
Evidence |
|
| APC |
IPI00215877 |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
2.997 |
Evidence |
|
| SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
EP300 |
IPI00478752 |
2.992 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
RAC1 |
IPI00219675 |
2.992 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
2.992 |
Evidence |
|
| CAMK1 |
CAMK1: Calcium/calmodulin-dependent protein kinase type 1 |
CAMKK1 |
IPI00166909 |
2.992 |
Evidence |
|
| CASP3 |
CASP3, CPP32: Caspase-3 precursor |
KCNIP3 |
KCNIP3, CSEN, DREAM, KCHIP3: Calsenilin |
2.992 |
Evidence |
|
| HSPA8 |
HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein |
PPID |
PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase |
2.992 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
NEDD4 |
NEDD4: Uncharacterized protein NEDD4 |
2.992 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
RAC1 |
IPI00219675 |
2.992 |
Evidence |
|
